Ocular Therapeutix

OCUL · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reports earnings in about 1 month

before market opens

Total Revenue

$10.7M

Previous year: $14.8M

-27.6%

EPS

-$0.38

Previous year: -$0.28

+35.7%

R&D Expense

$42.9M

Previous year: $20.7M

+106.7%

Sales & Marketing Exp

$14.1M

Previous year: $10.2M

+38.9%

G&A Expense

$16.3M

Previous year: $14.1M

+15.6%

Gross Profit

$9.44M

Previous year: $13.4M

Previous year: -$34.1M

Loading...

Ocular Therapeutix

Unlock previous datapoints

Upgrade

Ocular Therapeutix

Unlock previous datapoints

Upgrade

Ocular Therapeutix Revenue by Segment

Revenue by Segment

Product Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Collaboration Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.64B

P/E Ratio

-6.48

Sector

N/A

Industry

N/A

52-Week High

$16.1

52-Week Low

$6

R&D Expense

$42.9M

Sales & Marketing Exp

$14.1M

G&A Expense

$16.3M

Outstanding Shares

159.26M

Products

Get in Touch

Resources

Ocular Therapeutix

Ocular Therapeutix

Ocular Therapeutix

Ocular Therapeutix Revenue by Segment

Revenue by Segment

Product Revenue

Collaboration Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics